The UMass Chan Diabetes Center of Excellence (DCOE) congratulates Doug Melton, PhD, who was awarded the Doctor Juan Abarca International Award for Medical Sciences for pioneering the process of converting stem cells into insulin-producing beta cells. Dr. Melton is the founder of Harvard’s Stem Cell and Regenerative Biology Laboratory. For over a decade, the UMass DCOE has collaborated with the Melton lab to further characterize these cells’ survival and function in our novel humanized mouse models. We share a common goal of protecting them from autoimmune attack.
Recent Posts
- Top FDA Gene and Cell Therapy News: 2025 Year-End Recap
- Fatal Complication of Stem Cell Transplants Gets Its First FDA-Approved Therapy
- The 98% mystery: Scientists just cracked the code on “junk DNA” linked to Alzheimer’s
- New method preserves iPS cells for regenerative medicine
- MIT Scientists Have Discovered a Way To Rejuvenate the Immune System
- Lab-Grown Brain Tissue Finally Wires Itself Thanks to Crystal-Loaded Microgels


